Search Results
(2R,5S)-L-Menthol-5-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1,3-oxathiolane-2-carboxylate-[13C,15N2] Please inquire | Purity Not Available
BOC Sciences
(2R,5S)-L-Menthol-5-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1,3-oxathiolane-2-carboxylate-[13C,15N2] is the labelled analogue of (2R,5S)-L-Menthol-5-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1,3-oxathiolane-2-carboxylate, which is an intermediate of Lamivudine.
More Information Supplier Page(2R,5S)-L-Menthyl-5-(acetyloxy)-1,3-oxathiolane-2-carboxylate inquiry | 96%
Alfa Chemistry
(2R,5S)-N,5-bis(4-fluorophenyl)-5-hydroxy-2-(4-hydroxybenzyl)pentanamide (Ezetimibe Impurity)| ChemScene 1g | >98%
ChemScene
(2R,5S)-Piperazine-2,5-dicarboxylic acid inquiry | 96%
Alfa Chemistry
(2R,5S)-rel-1-Ethyl-2,5-dimethylpiperazine 1g | 95%
BLD Pharmatech Ltd.
(2R,5S)-rel-Diethyl 2,5-dibromohexanedioate 25g | 95%
BLD Pharmatech Ltd.
(2R,5S)-Ritlecitinib 1 mg | Purity Not Available
TargetMol
(2R,5S)-Ritlecitinib ((2R,5S)-PF-06651600) is a potent and selective inhibitor of JAK3 with IC 50 of 144.8 nM[1].
More Information Supplier Page(2R,5S)-Ritlecitinib 100 mg | Purity Not Available
TargetMol
(2R,5S)-Ritlecitinib ((2R,5S)-PF-06651600) is a potent and selective inhibitor of JAK3 with IC 50 of 144.8 nM[1].
More Information Supplier Page(2R,5S)-Ritlecitinib| ChemScene 25mg | >98%
ChemScene
(2R,5S)-Ritlecitinib ((2R,5S)-PF-06651600) is a potent and selective JAK3 inhibitor (IC50=144.8 nM) extracted from patent US20150158864A1, example 68.
More Information Supplier Page

